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Abstract 
Objective: The human Ureaplasma species are the most frequently isolated microbe from placentae of women who deliver 
preterm. The role of Ureaplasma spp. has been investigated in pregnancies <32 weeks, currently no studies have determined the 
prevalence of ureaplasmas in the moderate/late preterm period - the largest cohort of preterm infants.  
Study Design: Women delivering moderate/late preterm (n=477) and their infants/placentae (n=535) were recruited and swabs of 
chorioamnion tissue, chorioamnion tissue and cord blood were obtained at delivery. Swabs and tissues were utilized for culture and 
16S rRNA PCR for the presence of microorganisms, while cord blood was analysed for the presence of cytokines, chemokines and 
growth factors.  
Results: We detected microorganisms in 10.6% of all placentae (delivered late preterm (n=443) and at term (n=92)). Significantly, 
Ureaplasma spp. were the most prevalent microorganisms detected and their presence alone was associated with histological 
chorioamnionitis in moderate/late preterm and term placentae (p<0.001). The presence of ureaplasmas within the chorioamnion 
was also associated with elevated levels of granulocyte colony-stimulating factor (G-CSF) (p=0.02). 
Conclusions: These findings have important implications for infection and adverse pregnancy outcomes throughout gestation, and 
should be of major consideration for obstetricians and neonatologists. 
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Introduction 
Preterm birth (PTB; delivery < 37 weeks of gestation) is the leading cause of neonatal death and disability [1]. Globally, fifteen 
million infants are born preterm each year, accounting for 10% of all births [2]. PTB can be grouped according to gestational age, 
with infants born < 28 weeks considered to be extremely preterm; infants delivered between 29 – 32 weeks are considered to be 
very preterm and infants delivered between 32 - 36 weeks of gestation are referred to as moderate/late preterm (M/LPT) [1]. Of 
these, the M/LPT infants are the most prevalent and account for up to 85% of all PTBs worldwide.  
 
Infection of the female upper genital tract (UGT) is one of the most frequent causes of PTB [3, 4] with as many as one in three 
women experiencing an UGT infection during their pregnancy [2]. Currently, there is overwhelming evidence implicating UGT 
infection with early PTBs (< 32 weeks of gestation) and adverse neonatal outcomes [5-8]; however, there is limited evidence as to 
the prevalence of infection later in gestation (> 32 weeks). Studies have demonstrated that 25 – 40% of all PTBs are associated 
with infection, and the most common pathogens are the human Ureaplasma species [9-25]. While rates of ureaplasma infection are 
reported to be as high as 42% in some early PTB studies [23, 26, 27], the role of ureaplasmas in disease is complicated, as UGT 
infections that occur < 32 weeks of gestation are often polymicrobial [24, 28-30].  
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In this study, we investigated the prevalence and diversity of microorganisms infecting the chorioamnion of placentae delivered 
M/LPT or at term. We hypothesised that the presence of microorganisms would be associated with histological chorioamnionitis 
and adverse pregnancy outcomes, and aimed to provide novel insight into the role of infection late in gestation (> 32 weeks).  
 
Materials and Methods 
Study population  
From July 2010 to April 2013, patients delivering at the Good Samaritan Hospital (Cincinnati, Ohio; USA) were recruited and 
informed consent was obtained. Women with known congenital infections, HIV or fetal malformations were excluded. Ethics 
approval was granted by the review boards of the Good Samaritan Hospital (approval #09105-09-067) and Cincinnati Children’s 
Hospital Medical Centre (approval #2009-0236). All patients gave permission for the collection of their placentae upon delivery and 
for their medical records to be accessed and recorded in a de-identified database.  
 
Specimen Collection 
Following delivery, placentae were refrigerated in sterile containers and transported to a procedure room for sampling under strict 
aseptic conditions within 24 hours of delivery. The external placental surface was decontaminated using 70% alcohol and areas 
where the amnion had detached from the placenta were avoided, to minimise contamination. An incision was made into the amnion 
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(uppermost) membrane and the interface between the amnion and chorion was identified. The membranes were then peeled apart 
and the membrane interface was swabbed using sterile cotton swabs and placed into BBL-port-a-cul media (for isolation of bacteria 
and yeast; Becton Dickenson and Company, Maryland, USA) and into universal viral transport media (for isolation of 
ureaplasmas/mycoplasmas; Becton Dickenson and Company). Chorioamnion tissue was also excised and placed into sterile 
cryogenic vials. All samples were stored at – 80 °C prior to analysis. 
 
Culture of microorganisms from clinical samples 
Swabs stored in BBL port-a-cul media were inoculated into thioglycolate broth and onto a range of media, including: horse blood 
agar, chocolate agar, Schaedler anaerobe agar, Sabauraud’s dextrose agar, deMan Rogosa Sharpe agar and MacConkey no. 1 
agar (Thermo Fisher Scientific, Queensland, Australia). Media were incubated either aerobically, under 5% CO2 or anaerobically in 
jars (Anaerogen gas pack, 2.5L; Thermo Fisher Scientific) as appropriate. Agar plates were checked daily for signs of growth for up 
to 5 days. 
 
Swabs stored in universal viral transport media were cultured and quantified for the presence and numbers of Ureaplasma spp. 
colony-forming units (CFU) as previously described [31] using 10B broth and A8 agar [32]. 
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Tissue specimens were weighed and homogenised in sterile cryogenic vials containing 1 mL of sterile saline and sterile glass 
beads using the Mini Beadbeater-16 cell disruptor (Daintree Scientific; Tasmania, Australia). Tissues were homogenised in one 
minute cycles for up to four minutes and inoculated onto bacteriological media (as above) using a 10 µL sterile loop, into 
ureaplasma selective broth and into thioglycolate broth. The number of bacterial CFU was measured semi-quantitatively to 
determine the numbers of microbes within the chorioamnion tissue. Numbers of ureaplasmas were quantified as described above.  
 
Extraction of DNA from cultured microorganisms and chorioamnion tissue homogenates    
DNA extractions were performed using the QIAamp mini DNA extraction kit (Qiagen; Victoria, Australia). Extraction of DNA from 
cultured microorganisms (3 – 5 colonies per colony type) and tissue homogenates (approx. 500 µL) were performed using the 
manufacturer’s instructions for ‘tissues’. Extracted DNA was stored at -20 °C until required.  
 
Polymerase chain reaction (PCR) targeting the 16S rRNA gene 
16S rRNA PCR assays were performed in 20 µL reactions containing 4 µL of extracted DNA, 100 µM dNTPs (Roche; Queensland, 
Australia), 1 X PCR buffer (Tris HCl, KCl, (NH4)2SO4, pH 8.7 Invitrogen; Victoria, Australia), 2 mM MgCl2 (Invitrogen), 0.5 µM of 
forward (5’ C(C/T)GG(C/T)AG(C/T)CCACGCCG(C/T)AAA 3’) and reverse (5’ ACA(C/T)C(C/T)CACGACACGAGC(C/T)G 3’) 
primers (Sigma-Aldrich), 2.5 U Platinum taq DNA polymerase (Invitrogen) and sterile DNAse/RNAse free dH2O (Thermo Fisher 
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Scientific). PCR cycling consisted of initial denaturation at 95 °C for 5 minutes, followed by 30 cycles of 94 °C for 30 seconds, 
primer annealing at 60 °C for 30 seconds and extension at 72 °C for 30 seconds. DNA extracted from pure cultures of Gram 
positive and Gram negative organisms served as the template for positive control PCR reactions. Negative controls included 
replicates of master mix only and water substituted for template in order to identify contamination. 
 
Polymerase chain reaction (PCR) targeting the multiple banded antigen (mba) gene of Ureaplasma spp. 
In order to distinguish the two different ureaplasma species within the clinical isolates, PCR assays targeting the upstream 
conserved portion of the mba gene were performed as previously described [33] 
 
Sequencing of polymerase chain reaction amplicons 
PCR amplicons were sequenced to confirm the identity of each microorganism. PCR products were purified using the PureLink 
PCR purification kit (Invitrogen) according to the manufacturer’s instructions. 
 
PCR amplicons were labelled using the BigDye Terminator (BDT) v3.1 cycle sequencing kit (Thermo Fisher Scientific) as per the 
manufacturer’s instructions. Briefly, this included a PCR assay to incorporate the BigDye Terminator within the PCR amplicon and 
the labelled amplicons were then purified using EDTA (125 mM, pH 8.0), sodium acetate (3 M) and 100% ethanol. Sequencing was 
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carried out using the ion personal genome machine (PGM) molecular sequencer (Life Technologies, Victoria, Australia). Sequence 
data was imported and manipulated using the Geneious bioinformatics software (Biomatters Ltd., Auckland, New Zealand) and the 
identity of each clinical isolate was obtained using the basic local alignment search tool (BLAST; National Centre for Biotechnology 
Information [NCBI]). 
 
Detection of cytokines within cord blood  
Cord blood was collected by sterile needle and syringe at the time of delivery. Blood from each placenta was centrifuged and the 
serum was snap frozen in cryogenic vials until required. Cord blood was assayed using the Luminex Milliplex Map human 
cytokine/chemokine magnetic bead panel (Millipore, Billerica, USA). Concentrations of interleukin (IL)-6, IL-8, monocyte 
chemoattractant protein (MCP)-1 and granulocyte colony-stimulating factor (G-CSF) were calculated from standard curves using 
recombinant proteins.  
 
Statistical analysis 
Data are presented as the mean value, plus the standard error of the mean (SEM).  
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All data within this study were analysed using the statistical package for social sciences (SPSS) software program and data plotted 
using GraphPad Prism. Analyses included both binary logistic regression analysis and analysis of variance (ANOVA) to determine 
statistical significance between cohorts. Statistical significance was accepted as p < 0.05.  
 
Results 
Study population 
A total of 477 women and 535 infants (placentae) were recruited during the study period. The majority of women in this study were 
Caucasian (66.4%) or African-American (25.8%), with 26 women of mixed ethnicity and 8 women of Asian descent. Of the 535 
infants included in the study, 421 were singleton births and 114 infants were multiple births (54 sets of twins and two sets of 
triplets). Of the 477 women, 385 delivered 443 infants M/LPT, while 92 women delivered at term (all term deliveries were singleton 
births, n = 92 infants). Almost all women (> 97%) in our study had evidence of at least one prenatal care visit during their current 
pregnancy.  
 
Chorioamnion infection in M/LPT and term placentae 
Microorganisms were detected by culture and/or molecular methods in 57/535 (10.6%) placentae examined. Of the organisms 
isolated, all microbes were detected by molecular methods, while 52/61 (85.2%) were identified by traditional culture techniques. Of 
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these, all organisms were isolated from both swab and tissue specimens, with the exception of two placentae in which 
microorganisms were isolated from the tissue specimen but were not isolated from the swab. Of the placentae tested, the majority 
of infections were caused by a single microbial species (53/57; 93.0%); while four (7.0%) placentae were found to contain 
polymicrobial infections. A total of 61 microorganisms were isolated from 57 placentae and these included: Ureaplasma parvum, U. 
urealyticum, Streptococcus agalactiae (group B streptococcus), Bacteroides fragilis, Bifidobacterium spp., Gardnerella vaginalis, 
Propionibacterium spp. and Escherichia coli. Non-cultivable bacteria were detected by 16S rRNA PCR in six (9.8%) placentae 
(Table 1). Of the organisms isolated the human Ureaplasma spp. were the most prevalent, with U. parvum alone accounting for 
59.0% of all microorganisms within our study. No Lactobacillus spp. were detected by culture or PCR, nor were any fungi or yeasts 
detected.  
 
There was no difference in the incidence of microorganisms isolated from placentae of women who delivered M/LPT or at term 
(9.9% and 14.1%, respectively; p = 0.12) (Table 1).  
 
Association of infection with adverse pregnancy and neonatal outcomes in M/LPT and term pregnancies  
Placentae infected by microorganisms were more likely to exhibit histological chorioamnionitis (54.4%) than non-infected placentae 
(18.8%, p < 0.001) (Table 2) and this was irrespective of gestational age (Figure 1A&B) and ethnicity (p = 0.528; data not shown). 
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Neonates exposed to chorioamnion infection required oxygen or positive pressure respiratory support for prolonged (> 6 hrs) 
periods (21.0%), compared to those infants whose placentae had no detectable microorganisms (9%, p = 0.009), (Table 2). 
 
Ureaplasma spp. and other microorganisms in association with adverse pregnancy or neonatal 
outcomes 
As the human Ureaplasma spp. were the microorganisms most frequently isolated within our study, we also correlated the 
presence of these microorganisms with adverse pregnancy or neonatal outcomes. Due to the small number of microorganisms 
other than Ureaplasma spp. present, it was not possible to further divide these microorganisms; therefore we compared the 
outcomes of women whose placentae was infected/colonised with Ureaplasma spp. and those whose placentae was infected with 
microorganisms other than the ureaplasmas (‘other’ microorganisms). In some cases, women delivered multiple infants/placentae 
in which one placenta was found to be infected, while the other was not (n = 3); or placentae were found to contain both 
ureaplasmas and ‘other’ microorganisms (n = 4). As a consequence, data from n = 7 women were excluded from these analyses.  
 
The presence of Ureaplasma spp. in placentae (n = 32) was associated with decreased maternal age (24.2 ± 0.8 yrs; p = 0.002), 
when compared to women whose placentae were infected with ‘other’ microorganisms (n = 12; 28.2 ± 1.4 yrs) and those women 
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whose placentae had no detectable microorganisms (n = 427; 27.8 ± 0.3 yrs). There were no other differences in the maternal 
demographic data (shown in Table 2) or the incidence of adverse pregnancy outcomes between these groups of women.  
  
The presence of Ureaplasma spp. within placentae (n = 531), but not of other microorganisms, correlated with histological 
chorioamnionitis (26/38; 68.4% vs. 26.7%, respectively; p < 0.001). Of the placentae infected with ureaplasmas 12 (31.6%) showed 
no evidence of inflammation, 14 (36.8%) placentae showed only mild evidence of chorioamnionitis (grade 1) and 12 (31.6%) 
demonstrated severe histological chorioamnionitis (grades 2 or 3) (Figure 1B). There was no difference in the prevalence of U. 
parvum or U. urealyticum clinical isolates in placentae with or without histological chorioamnionitis (p = 0.10) or in placentae that 
were delivered late preterm or at term (p = 0.076; data not shown). Interestingly, the presence of histological chorioamnionitis was 
significantly associated with spontaneous (but not medically indicated) M/LPT birth when Ureaplasma spp. infection was present 
(22.5% vs. 3.1%, p < 0.001). There were no other significant correlations between the presence of ‘other’ microorganisms and 
spontaneous delivery, in the presence or absence of histological chorioamnionitis (3.4% vs. 1.8%, respectively). 
 
Placental infection with Ureaplasma spp. and other microorganisms was associated with elevated cord 
blood cytokines  
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Chorioamnion infection, irrespective of aetiology, was associated with elevated cord blood factors. Placentae which were found to 
have chorioamnion infection demonstrated significantly higher concentrations of IL-8 (536 pg/mL) and G-CSF (403 pg/mL), 
compared to cord blood from pregnancies in which no chorioamnion infection was detected (56 pg/mL and 231 pg/mL, p = 0.03 and 
p= 0.04, respectively; data not shown). 
 
Furthermore, we also investigated if specific cord blood cytokines were associated with infection with particular microorganisms. 
Detection of Ureaplasma spp. within the chorioamnion was associated with elevated levels of G-CSF (p = 0.02; Figure 2D), but not 
with the factors IL-6 (Fig. 2A), IL-8 (Fig. 2B) and MCP-1 (Fig. 2C). By contrast, cord blood collected from pregnancies in which the 
chorioamnion was infected by microorganisms other than Ureaplasma spp. demonstrated higher levels of IL-8 (p = 0.01, Figure 
2B). 
 
Discussion 
Infections of the female UGT are associated with PTB and up to 40% of all PTBs are attributed to infection [3]. While previous 
studies have identified an association between UGT infections in pregnancy and early PTBs (< 32 weeks of gestation) [3, 4, 24, 34, 
35], currently no studies have investigated the prevalence of UGT infection in late gestation (> 32 weeks). In our large study of 535 
placentae we have identified, for the first time, that chorioamnion infection was present in 10.6% of all M/LPT and term pregnancies 
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and there were no differences in the incidence of chorioamnionitis in M/LPT or term placentae, nor were there any major 
differences in the prevalence of signs/symptoms of infection in women experiencing chorioamnionitis. This highlights why it is so 
difficult to identify and treat women with asymptomatic UGT infection and chorioamnionitis during pregnancy.  
 
Within our study, colonisation/infection of placentae was predominantly caused by a single microorganism and the human 
Ureaplasma spp. were the most prevalent microorganisms identified within the chorioamnion, accounting for more than 68% of all 
isolates within the study. While 70% of the women in our study delivered vaginally, we isolated no Lactobacillus spp. within any 
chorioamnion tissue specimens tested. Lactobacillus spp. have been isolated in up to 90% of vaginal specimens [36] and the 
absence of this microorganism within placental tissue confirms that our methods of collection and sampling have 
eliminated/circumvented vaginal microflora contamination. Furthermore, the majority of microorganisms detected within these 
placentae are consistently associated with intraamniotic infection and studies have demonstrated the presence of these 
microorganisms in early PTBs (< 32 weeks) [21, 37]; while other studies have linked their presence to bacterial vaginosis and a 
two-fold increase in the likelihood of delivering preterm [38]. 
 
Perhaps the most significant finding of this study was that infection of the chorioamnion was associated with histological 
chorioamnionitis, regardless of gestational age. We identified an increased prevalence of chorioamnionitis in placentae that were 
18 
 
infected with microorganisms, when compared to placentae from women with no detectable microorganisms. These findings also 
confirm the findings of others, who demonstrated that UGT infection during pregnancy was associated with chorioamnionitis [24, 
28, 29]; however, our study is the first to show such high rates of infection and chorioamnionitis in the M/LPT and term gestational 
period, indicating that chorioamnionitis is a significant finding, regardless of gestational age.  
 
This study further investigated the role of individual microorganisms with adverse pregnancy or neonatal outcomes and identified 
that infection with Ureaplasma spp., but not other microorganisms, was significantly associated with chorioamnionitis and 
spontaneous M/LPT delivery. Previous studies have reported associations between infection with ureaplasmas and PTB 
accompanied by histological chorioamnionitis; however, these studies focused on early PTBs when the majority of infections are 
polymicrobial [17, 24]. As a result, researchers have not yet been able to confidently claim that these microorganisms are true 
aetiological agents of PTB or chorioamnionitis. However, in this large study population of 535 placentae we have demonstrated that 
infection is predominantly caused by a single microorganism and that Ureaplasma spp. infection was independently associated with 
chorioamnionitis, regardless of gestational age.  
 
Significantly, higher concentrations of IL-8 and G-CSF were detected within cord blood in association with chorioamnion infection 
(regardless of the aetiology), when compared to pregnancies with no infection. These results are similar to the findings of others 
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who demonstrated that infection of the amniotic fluid or placentae was associated with elevated levels of cytokines within amniotic 
fluid [30, 39-41]. In this current study, the presence of other microorganisms (not including Ureaplasma spp.) was associated with a 
higher concentration of IL-8 within cord blood; while the presence of Ureaplasma spp. was associated with a elevated levels of G-
CSF. G-CSF is a cytokine that affects the proliferation and differentiation of neutrophil progenitors and previous studies have 
identified elevated levels of G-CSF in association with chorioamnionitis [42]; however, ours is the first study to investigate the 
concentrations of cord blood cytokines in relation to placental infection. These findings suggest that G-CSF may be a potential 
biomarker in the identification of asymptomatic chorioamnionitis or ureaplasma infections during pregnancy. 
 
While we identified placental infection in 10.6% of M/LPT and term pregnancies, we found little evidence that UGT infection was 
associated with M/LPT delivery. Therefore, the question remains as to the other likely causes or aetiologies of M/LPT birth. Some 
known precursors and risk factors include: spontaneous preterm labour, pPROM, cervical incompetence, preeclampsia, multiple 
gestation pregnancies, intrauterine growth restriction, prior Cesarean section delivery, chorioamnionitis, and fetal distress [43]. 
Within our study, many of these factors (which may predispose to PTB) were present. Given the presence of these factors, it is 
probable that a combination of these various precursors/risk-factors contributed to delivery in the M/LPT period, and as such, the 
aetiology of M/LPT birth is likely to be multifactorial.  
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To the best of our knowledge, this is the first study to report the prevalence of chorioamnion infection in M/LPT placentae. Greater 
than 70% of all PTBs worldwide occur in the M/LPT period [2]; therefore, the number of infants potentially exposed to chorioamnion 
infection in this period is far greater (estimated to be 1.3 million per year) than the number of infants delivered at less than 32 
weeks of gestation (702 000; Table 3). This also highlights that irrespective of gestation, UGT infections during pregnancy are 
associated with adverse outcomes and these findings should be a major consideration for microbiologists and clinicians, including 
obstetricians and neonatologists.   
 
While this study has extended our knowledge of chorioamnion infection, there are some limitations which should be noted. More 
than 50% of the women in this study were treated with intrapartum antibiotics. While the dosage and identity of these antibiotics 
were not available for analysis, the use of antibiotics for prolonged periods (> 3 hours) may have decreased the overall numbers of 
microorganisms isolated from these placentae and therefore the rate of chorioamnion infection may be higher than is reported 
within our study. While we utilized both culture and molecular detection methods and isolated both cultivable and non-cultivable 
microorganisms, additional investigation using more sensitive techniques, such as deep sequencing, may be useful for determining 
the true prevalence of infection, in order to fully characterise infection throughout gestation.  
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In conclusion, the presence of chorioamnion infection is an important finding, regardless of gestation. This study demonstrated that 
chorioamnion infection directly correlates with inflammation of the chorioamnion (chorioamnionitis) and adverse pregnancy and 
neonatal outcomes. This is also the first study to demonstrate that Ureaplasma spp. are independently associated with histological 
chorioamnionitis and elevated levels of the cord blood cytokine G-CSF, regardless of gestation. These findings suggest that 
ureaplasmas are a cause of inflammation, and that other immune factors may be involved in the severity of inflammation within the 
upper genital tract during pregnancy. 
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a Frequency- the total number of microorganisms isolated by standard culture, growth in enrichment broth or by 16S rRNA PCR.  
b Quantitative analysis was not always possible, as some microorganisms were isolated in enrichment broth or by PCR only. Quantitative 0 
analyses shown where possible, in CFU/g of chorioamnion tissue. 1 
MICROORGANISMS DETECTED WITHIN PLACENTAE 
 Late preterm (32 – 36 weeks) Term (> 37 weeks) 
Microorganism Frequencya (%) Bacterial load (mean)b Frequencya (%) Bacterial load (mean)b 
Ureaplasma parvum 27 (58.7%) 4.86 x 108 9 (60.0%) 1.16 x 108 
Ureaplasma urealyticum 6 (13.0%) 2.92 x 108 0 (0.0%) -  
Uncultured bacterium 3 (6.5%) - 3 (20.0%) - 
Streptococcus agalactiae (GBS) 3 (6.5%) 1 x 103 3 (20.0%) 1 x 106 
Bacteroides fragilis 2 (4.3%) 1 x 103 0 (0.0%) - 
Bifidobacterium spp. 2 (4.3%) 1 x 103 0 (0.0%) - 
Gardnerella vaginalis 1 (2.2%) 1 x 103 0 (0.0%) - 
Escherichia coli 1 (2.2%) 1 x 103 0 (0.0%) - 
Propionibacterium spp. 1 (2.2%) 1 x 103 0 (0.0%) - 
TOTAL NUMBER OF ORGANISMS ISOLATED 46  15  
FREQUENCY OF INFECTIONc 44/443 (9.9%) - 13/92 (14.1%) - 
Infection and chorioamnionitis 26/44 (59.1%) - 5/13 (38.5%) - 
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c Some placentae (n = 4) contained polymicrobial infections, in which more than one organism was isolated from the chorioamnion. The 2 
numbers within this table represent the total number of placentae which were found to have infection. 3 
  4 
27 
 
MATERNAL OUTCOMES 
 Chorioamnion infection (n = 47a) No chorioamnion infection detected (n = 427a) Significance 
Maternal age (mean, range) 25.0 ± 0.7 (17 – 38) 27.8 ± 0.3 (15 – 43) NSb  
Gravidac (mean, range) 2.2 ± 0.2 (1 – 5) 2.5 ± 0.1 (1 – 11) NS 
Parityd (mean, range) 1.9 ± 0.1 (1 – 4) 2.1 ± 0.1 (1 – 10) NS 
At least one sign/symptom of infectione 5/47 (10.6%) 29/427 (6.8%) NS 
Cervical incompetence and/or preterm labour 26/47 (55.3%) 230/427 (53.9%) NS 
Antibiotics administered during labourf 25/47 (53.2%) 238/427 (55.7%) NS 
Preterm premature rupture of membranes 
(pPROM) 
17/47 (36.2%) 158/427 (37.0%) NS 
Mode of delivery    
‐ Vaginal 42/47 (89.4%) 290/427 (67.9%) 0.01 
‐ Cesarean 5/47 (10.6%) 135/427 (31.6%) NS 
‐ Undisclosed 0/47 (0.0%) 2/427 (0.5%) NS 
NEONATAL OUTCOMES 
 Chorioamnion infection  (n = 57) No chorioamnion infection detected (n = 
478) 
Significance 
28 
 
a Some women (n = 3) delivered multiple placentae and one placenta was found to be infected, while the other was shown to be uninfected by 5 
culture and 16S rRNA PCR. Data from these women with contrasting placental microbiology results were excluded from this analysis 6 
b NS – Not statistically significant 7 
c Gravida - Number of clinical pregnancies 8 
d Parity - Number of viable offspring resulting from all pregnancies 9 
Gestational age at delivery (mean, range) 35.7 ± 0.3 (32 – 41) 35.6 ± 0.1 (32 - 41) NS 
Birth weight (mean, range) 2642.4 ± 84.6  
(1380 – 3925) 
2658.0 ± 29.8  
(1060 - 4530) 
NS 
Placental weight (mean, range) 441.3 ± 16.2 (199 – 710.7) 428.7 ± 5.8  (132 - 1099) NS 
Histologic Chorioamnionitisg  31/57 (54.4%) 90/478 (18.8%) < 0.001 
‐ Maternal Stage 1.5 (1 – 3) 1.0 (1 – 3) NS 
‐ Fetal Stage 3.0 (1 – 3) 2.5 (1 – 3) NS 
Continuous positive airway pressure 
(CPAP) 
12/57 (21.0%) 48/478 (10.0%) NS 
Required oxygen support for > 6 hrs 12/57 (21.0%) 43/478 (9.00%) 0.009 
Diagnosed RDS8 10/57 (17.5%) 43/478 (9.00%) NS 
Length of Stay 7.0 ± 1.1 (1 – 37) 6.1 ± 0.3 (1 - 43) NS 
29 
 
e Signs and symptoms of infection included: maternal temperature > 38 °C, uterine or abdominal tenderness, foul-smelling vaginal discharge, 10 
maternal tachycardia (> 120 bpm) or fetal tachycardia (> 160 bpm)  11 
f Antibiotics were administered > 3 hours prior to delivery. The type and dose of antibiotics was not recorded.  12 
g Chorioamnionitis was assessed using tissue sections from each placenta according to criteria set out by Redline et  al. (2003). Maternal and 13 
fetal grades of chorioamnionitis are listed as median and range.  14 
  15 
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 Early PTB (< 31 weeks) M/LPTB (32 – 36 
weeks) 
Prevalence in the preterm population1 15.6% 84.4% 
Total number of pregnancies2 2.3 million 12.7 million 
Rate of UGT infection3 Approx. 30% 10.4% 
Number of births potentially affected by 
infection4 
702 000  1.3 million 
1 Statistics from [44] 16 
2 Number of births estimated by multiplying the total number infants delivered preterm (15 million annually [1] by the total prevalence 17 
(percentage) of each population.  18 
3 Early PTB rate of intraamniotic infection as quoted in [2], while LPT birth rate has been identified within the present study.  19 
4 Calculated values based on proportion of intraamniotic infection within each population. 20 
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Figure 1. (A) The severity of chorioamnionitis was similar among moderate/late preterm and term placentae; (B) Ureaplasma spp., but not 21 
other microorganisms were associated with histological chorioamnionitis and the severity of inflammation was greater when ureaplasmas are 22 
present. Data are presented as the mean, plus or minus the standard error of the mean (SEM) and data were analysed using analysis of 23 
variance (ANOVA). 24 
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Figure 2. Cord blood cytokine, chemokine and growth factor profiles for (A) IL-6, (B) IL-8, (C) MCP-1 and (D) G-CSF differed among women 27 
infected with Ureaplasma spp., those infected with ‘other’ microorganisms and those women in whom no infection was identified. Data are 28 
presented as the mean, plus or minus the standard error of the mean (SEM) and data was analysed using analysis of variance (ANOVA).  29 
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